Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.460
-0.050 (-3.31%)
Feb 5, 2026, 2:16 PM EST - Market open
Equillium Revenue
Equillium had revenue of $4.39M in the twelve months ending September 30, 2025, down -90.43% year-over-year. In the year 2024, Equillium had annual revenue of $41.10M with 13.89% growth.
Revenue (ttm)
$4.39M
Revenue Growth
-90.43%
P/S Ratio
14.82
Revenue / Employee
$125,486
Employees
35
Market Cap
88.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.10M | 5.01M | 13.89% |
| Dec 31, 2023 | 36.08M | 20.33M | 128.97% |
| Dec 31, 2022 | 15.76M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 106.83M |
| Fortress Biotech | 62.30M |
| Champions Oncology | 58.42M |
| Pyxis Oncology | 2.82M |
| Precision BioSciences | 698.00K |
| aTyr Pharma | 190.00K |
| eXoZymes | -700.00 |
EQ News
- 2 days ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Equillium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 3 months ago - Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript - Seeking Alpha
- 3 months ago - Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 - GlobeNewsWire
- 4 months ago - Equillium Announces Leadership and Corporate Updates - GlobeNewsWire
- 4 months ago - NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor - GlobeNewsWire
- 5 months ago - Equillium to Participate in the Cantor Global Healthcare Conference 2025 - Business Wire